Page last updated: 2024-08-23

dobutamine and pyrazines

dobutamine has been researched along with pyrazines in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosokawa, T; Kojima, M; Mori, T; Yabuuchi, Y; Yamashita, S1
Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S1
Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Valkema, R; van Lingen, A; Visser, FC1
Brouwer, EM; Saris, WH; Schiffelers, SL; van Baak, MA1
Hesselink, MK; Hoeks, J; Hul, GB; Saris, WH; Schrauwen, P; van Baak, MA; Vidal, H1
Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; ZacĂ , V1

Reviews

2 review(s) available for dobutamine and pyrazines

ArticleYear
FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.
    European heart journal, 1997, Volume: 18 Suppl D

    Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1997
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
    Heart failure reviews, 2009, Volume: 14, Issue:4

    Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents

2009

Trials

1 trial(s) available for dobutamine and pyrazines

ArticleYear
Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:4

    Topics: Adult; Albuterol; Carrier Proteins; Dobutamine; Dose-Response Relationship, Drug; Energy Metabolism; Fats; Fatty Acids, Nonesterified; Glucose; Humans; Ion Channels; Male; Mitochondrial Proteins; Muscle, Skeletal; Oxygen Consumption; Pyrazines; Receptors, Adrenergic, beta; Thigh; Uncoupling Protein 3

2003

Other Studies

3 other study(ies) available for dobutamine and pyrazines

ArticleYear
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:3A

    Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Cats; Dobutamine; Dogs; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Phentolamine; Pindolol; Pyrazines; Quinolines; Rabbits; Rats; Sodium-Potassium-Exchanging ATPase; Theophylline

1984
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:3A

    Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines

1984
Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man.
    Metabolism: clinical and experimental, 1998, Volume: 47, Issue:12

    Topics: Adrenergic beta-Agonists; Adult; Blood Chemical Analysis; Blood Pressure; Body Temperature Regulation; Carbohydrate Metabolism; Dobutamine; Energy Metabolism; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipolysis; Male; Pyrazines; Receptors, Adrenergic, beta-1; Respiration

1998